Résumé
Epithelioid hemangioendothelioma is a multifocal tumor that rarely metastasizes. It is difficult to diagnose, most often it is an incidental finding in young asymptomatic women. The radiologic pattern is heterogeneous. Histologic confirmation of Weibel-Palade bodies or immunohistochemistry based on specific tumor markers such as factor VIII and CD34 are the most important finding to confirm the diagnosis. We report a 21 years old woman Presenting with cough and dyspnea. A chest X ray was suggestive of tuberculosis. Sputum smears were negative for acid fat bacilli and the tuberculin test was negative. A chest CAT scan showed multiple nodular lesions. A surgical biopsy of the lesions confirmed the presence of a hemangioendothelioma. The patient was initially treated with prednisone and azathioprine without response. Thereafter, the patient is without treatment and without evidence of disease progression.
Sujets)
Humains , Femelle , Jeune adulte , Hémangioendothéliome épithélioïde/diagnostic , Tumeurs du poumon/diagnostic , Azathioprine/usage thérapeutique , Prednisone/usage thérapeutique , Hémangioendothéliome épithélioïde/traitement médicamenteux , Tumeurs du poumon/traitement médicamenteux , Antimétabolites antinéoplasiquesRésumé
We present a case of multifocal epithelioid hemangioendothelioma occurring in an adolescent boy who presented with massive hemoptysis and showed a pulmonary perihilar mass with multiple lesions in the liver and two lytic lesions in the ribs on imaging. The diagnosis was confirmed by lung and liver biopsy. He was treated with oral steroids.
Sujets)
Biopsie , Tumeurs osseuses/diagnostic , Tumeurs osseuses/traitement médicamenteux , Enfant , Diagnostic différentiel , Glucocorticoïdes/administration et posologie , Glucocorticoïdes/usage thérapeutique , Hémangioendothéliome épithélioïde/diagnostic , Hémangioendothéliome épithélioïde/traitement médicamenteux , Hémoptysie/traitement médicamenteux , Hémoptysie/étiologie , Humains , Tumeurs du foie/diagnostic , Tumeurs du foie/traitement médicamenteux , Tumeurs du poumon/diagnostic , Tumeurs du poumon/traitement médicamenteux , Mâle , Tumeurs primitives multiples/diagnostic , Tumeurs primitives multiples/traitement médicamenteux , Côtes/anatomopathologie , Résultat thérapeutiqueRésumé
Los hemangioendoteliomas son tumores vasculares que pueden afectar pulmón. Abarcan desde lesiones benignas o de baja malignidad hasta lesiones de malignidad intermedia, como el hemangioendotelioma epitelioide o el polimorfo. El hemangioendotelioma epitelioide es un tumor muy raro que afecta principalmente a mujeres menores de 40 años, ha sido asociado al uso de anticonceptivos orales y a la inhalación de cloruro de vinilo. Sólo se describen en la literatura unos cincuenta casos de hemangioendotelioma epitelioide pulmonar y muy pocos pleurales. Inmunomarcadores permiten caracterizar este tipo de neoplasias. El diagnóstico diferencial incluye tumores benignos y malignos y el pronóstico es poco predecible. No hay consenso en cuanto al tratamiento, el cual ha incluído cirugía, carboplatino más etopósido e interferón. Se presenta una paciente de 37 años, se discuten los hallazgos clínicos su tratamiento y evolución.
The hemangioendotheliomas are vascular tumors that may involve lungs. The malignancy of these tumours can be benign, low or intermediate, such as the epithelioid or the polymorph hemangioendothelioma. The epithelioid hemangioendothelioma is an unusual tumour that appears more frequently in females, younger than 40 years of age. It has been associated to the use of oral contraceptives and the inhalation of vinile chloride. Only some 50 cases of pulmonary epithelioid hemangioendothelioma and few of pleural origin have been described in the literature. Immunomarkers may help to characterize this kind of tumours. The differential diagnosis includes malignant and benign tumours and its prognosis is hard to predict. Its therapy remains controversial, surgery, chemotherapy with carboplatin plus etoposide and interferon were used. The case of a 37 year old female is presented; clinical findings, therapy and outcome are discussed.
Sujets)
Humains , Adulte , Femelle , Hémangioendothéliome épithélioïde/diagnostic , Hémangioendothéliome épithélioïde/anatomopathologie , Hémangioendothéliome épithélioïde/traitement médicamenteux , Hémangioendothéliome épithélioïde/thérapie , Tumeurs de la plèvre/diagnostic , Tumeurs de la plèvre/anatomopathologie , Tumeurs de la plèvre/traitement médicamenteux , Tumeurs de la plèvre/thérapie , Spectroscopie par résonance magnétique , Morphine/usage thérapeutique , Thorax , Tomodensitométrie , Thalidomide/usage thérapeutiqueRésumé
Relata-se o caso de um paciente exposto profissionalmente a asbesto por dez anos e portador de um tumor pleural muito raro, o hemangioendotelioma epitelióde. O paciente apresentava derrame pleural serohemorrágico, sem evidência de células neoplásicas e com predomínio de linfócitos. A biópsia pleural por agulha revelou processo inflamatório crônico inespecífico, com áreas de tecido mixóide. A videotoracoscopia mostrou nódulos difusos nas pleuras parietal e visceral. A biópsia revelou neoplasia mesenquimal e eram semelhantes às áreas focais observadas na primeira biópsia. O estudo imunohistoquímico demonstrou a presença dos marcadores vasculares CD31, CD34 e Fator VIII, caracterizando a origem vascular do tumor. O paciente foi tratado com cisplatina e ectoposide, tendo o óbito ocorrido três meses após o diagnóstico.